Sense Neuro Diagnostics

company

About

Sense Neuro Diagnostics is a developer of non-invasive medical devices for neurological conditions.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.24M
Industries
Health Care,Health Diagnostics,Medical,Neuroscience
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Sense Neuro Diagnostics is a medical technology company focused on improving outcomes for stroke and brain injury patients through technology innovations that enable faster detection and more effective triage. Sense is developing non-invasive technology to enable continuous, real-time brain injury monitoring as well as rapid detection of traumatic brain injury and important stroke subtypes—ischemic stroke with large vessel occlusion, ischemic stroke without large vessel occlusion, and intracerebral hemorrhage. Learn about the ongoing pivotal trial for continuous monitoring of intracranial hemorrhage, and successful first-in-human pilot study of triage technology to determine stroke subtype.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.39M
Sense Neuro Diagnostics has raised a total of $1.39M in funding over 2 rounds. Their latest funding was raised on Sep 6, 2016 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 6, 2016 Grant $1.24M 1 National Science Foundation Detail
Jun 26, 2015 Grant $149.41K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Sense Neuro Diagnostics is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant